GoodHemp seed varieties and genetics are distributed in Canada by Tritium 3H, Inc. (T3H), which focuses on hemp subject testing, licensed seed manufacturing, commercialization and distribution of commercial hemp varieties. The approval from Health Canada broadens the geographic alternatives for GoodHemp and permits growers to entry prime quality seeds by means of Tritium for the 2021 rising season.
“The Health Canada approval demonstrates the stability and compliance of our cultivars,” mentioned Arcadia CEO Matt Plavan. “We are happy to report we have already shipped the first GoodHemp seed order to Tritium 3H to bring our CBD-dominant, short-day varieties to Canada’s industrial hemp growers for the 2021 planting season.”
GoodHemp varieties accredited by Health Canada embody:
- Umpqua: CBD-dominant, early photoperiod selection for each the smokable and CBD extraction markets. Prized for its distinctive terpene profile.
- Rogue: CBD-dominant, high-yielding intermediate photoperiod selection for the CBD extraction markets. Brings distinctive yields below low planting densities.
- Santiam: CBD-dominant, early photoperiod selection with distinctive utility in northern latitudes for each the smokable and CBD extraction markets. Delivers step change yield potential.
“We’re pleased to partner with Arcadia in bringing these high CBD, early maturing feminized hybrids to Canada,” mentioned Jayme Hunter, Tritium 3H CEO. “These GoodHemp varieties performed well in our 2020 field trials with excellent yield, uniformity and quality; they are hybrids with excellent performance potential in Canada’s hemp growing regions.”
GoodHemp is Arcadia’s industrial portfolio of genetically superior hemp seeds, transplants and extracts launched in 2019. Since then, Arcadia has been rapid-prototyping novel non-GM hemp varieties that focus on high quality and efficiency traits extremely desired by growers to beat their best challenges. GoodHemp varieties have been field-tested extensively in regional and nationwide trials by the T3H and Arcadia groups.
For extra details about GoodHemp’s distinctive seed varieties, go to www.growgoodhemp.com.
About Arcadia Biosciences
Arcadia Biosciences (Nasdaq: RKDA) is a pacesetter in science-based approaches to enhancing the standard and dietary worth of crops and meals elements. The firm’s GoodHempTM seed catalog delivers genetically superior hemp seeds, transplants and extracts, bringing the advantages of recent agriculture to an rising crop. The firm’s GoodWheat™ branded elements ship well being advantages to customers and allow shopper packaged items corporations to distinguish their manufacturers within the market. For extra data, go to www.arcadiabio.com.
About Tritium 3H
Tritium 3H works collaboratively with breeders, producers and finish customers to deliver well-adapted hemp varieties with superior efficiency traits to market. It’s the objective of T3H to maximise worth and return for companions at every step of the availability chain. For extra data, go to www.growtritium.com.
Note Regarding Forward-Looking Statements
This press launch incorporates forward-looking statements throughout the that means of the Private Securities Litigation Reform Act of 1995, together with statements concerning the Health Canada approval and the influence of that approval on Arcadia’s enterprise and monetary outcomes. Forward-looking statements are topic to dangers and uncertainties that would trigger precise outcomes to vary materially, and reported outcomes shouldn’t be thought-about as a sign of future efficiency. These dangers and uncertainties embody, however should not restricted to: the continued efficiency of the seed varieties to keep up Health Canada approval; the adequacy of hemp seed demand and pricing to assist our projections; the corporate’s compliance with legal guidelines and rules that influence the corporate’s enterprise, and modifications to such legal guidelines and rules; and the corporate’s future capital necessities and skill to fulfill its capital wants. Further data concerning these and different components that would have an effect on the corporate’s monetary outcomes is included in filings the corporate makes with the Securities and Exchange Commission every so often, together with the part entitled “Risk Factors” and extra data set forth in its Form 10-Okay for the 12 months ended December 31, 2020 and different filings. These forward-looking statements converse solely as of the date hereof, and Arcadia Biosciences, Inc. undertakes no responsibility to replace these forward-looking statements.
SOURCE Arcadia Biosciences, Inc.